簡易檢索 / 詳目顯示

研究生: 鄭獻仁
Cheng, Hsien-Jen
論文名稱: 研究登革出血熱致病機轉之分子相似機制:以蛋白質體學分析登革病毒非結構性蛋白1抗體辨識之內皮細胞與血小板細胞表面的自體抗原
Study on the mechanism of molecular mimicry for dengue hemorrhagic fever pathogenesis : Proteomic analysis of endothelial cell and platelet autoantigens recognized by dengue virus nonstructural protein 1 antibodies
指導教授: 林以行
Lin, Yee-Shin
學位類別: 博士
Doctor
系所名稱: 醫學院 - 基礎醫學研究所
Institute of Basic Medical Sciences
論文出版年: 2009
畢業學年度: 97
語文別: 英文
論文頁數: 141
中文關鍵詞: 蛋白質双硫鍵轉位酶血小板內皮細胞蛋白質體學分子相似性登革出血熱登革病毒非結構姓蛋白1自體抗體自體抗原
外文關鍵詞: dengue virus (DV), nonstructural protein 1 (NS1), dengue hemorrhagic fever (DHF), autoantibody, autoantigen, platelet, protein disulfide isomerase (PDI), proteomics, endothelial cell, molecular mimicry
相關次數: 點閱:112下載:1
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 中文摘要
    登革病毒(dengue virus, DV) 的感染會導致血管滲漏與出血的症狀,先前的研究顯示登革病毒非結構性蛋白質1(DV NS1)的抗體會與內皮細胞有結合的現象,並且導致內皮細胞凋亡與活化宿主的免疫反應。在本論文中,我們發現DV NS1的抗體會辨識內皮細胞表面之目標蛋白質(target proteins),包括氫離子傳送蛋白/ATP合成酶之刍鏈(刍 chain of H+-transporter/ATP synthase, ATPase 刍 chain)、蛋白質双硫鍵轉位酶(protein disulfide isomerase, PDI)、中間絲蛋白(vimentin intermediate filament)與60 kD熱休克蛋白(heat shock protein 60, HSP60),這些目標蛋白質表現於內皮細胞株HMEC-1的細胞表面,並與anti-DV NS1的抗體結合到內皮細胞的位置相同(co-localization)。而這些目標蛋白質的抗體與內皮細胞結合的現象會被DV NS1所抑制。Anti-DV NS1抗體會與目標蛋白質結合,反之亦然。根據這些實驗結果顯示在DV NS1與目標蛋白質之間可能具有分子相似性(molecular mimicry)的機制存在。利用胺基酸序列比對與辨識決定位(epitope)分析DV NS1與目標蛋白質,發現DV NS1的C端胺基酸第311-330 (P311-330)可能是重要的epitope,並且與目標蛋白質具有序列上的相似性。其中以ATPase、PDI和HSP60與DV NS1的胺基酸P311-330序列相似度較高,與DV NS1結合到anti-ATPase、anti-PDI與anti-HSP60抗體的程度較高於anti-vimentin抗體的結果相符合。在登革出血熱(DHF)病人的血清研究發現,病人血清結合到內皮細胞的程度會被P311-330合成的片段胜肽所抑制。先前的研究證實anti-DV NS1抗體亦會與血小板有交叉反應(cross-reactivity)的情形。在本研究中,我們發現anti-DV NS1抗體可以辨識到血小板細胞膜上的PDI,anti-DV NS1抗體會抑制PDI的活性與血小板的凝集作用,而抗體經過PDI預先吸附處理(pre-absorption)可以清除其所造成的抑制現象。Anti-PDI抗體亦會與P311-330的合成片段胜肽結合,而預先處理P311-330可以減少anti-DV NS1與anti-PDI抗體結合到血小板的程度。與anti-DV NS1抗體作用相似,anti-P311-330抗體會減低PDI的活性與血小板的凝集作用。除此之外,DHF病人的血清交叉反應到血小板的程度可以被PDI與P311-330的預先吸附處理所抑制,而DHF病人血清抑制血小板凝集的作用亦會被PDI與P311-330的預先吸附處理所清除。因此,anti-DV NS1抗體會與血小板細胞表面上的PDI結合進而抑制血小板的凝集作用,這與登革致病機制可能有相關性。此外,DV NS1的P311-330是登革熱致病機轉中自體免疫反應的重要辨識決定位。

    Abstract
    Dengue virus (DV) infection may cause vascular leakage and hemorrhage. We previously showed a mechanism of molecular mimicry in which antibodies against DV nonstructural protein 1 (NS1) cross-reacted with endothelial cells and induced them to undergo apoptosis and immune activation. In this study, we found that the target proteins recognized by anti-DV NS1 antibodies on HMEC-1 endothelial cells were beta chain of H+-transporter/ATP synthase (ATPase 刍 chain), protein disulfide isomerase (PDI), vimentin intermediate filament, and heat shock protein 60 (HSP60). We confirmed their expression on the HMEC-1 cell surface. Co-localization was shown between the binding sites of anti-DV NS1 antibodies and target proteins on HMEC-1 cells. The antibodies against the target proteins cross-reacted with HMEC-1 cells, but DV NS1 protein pre-absorption inhibited cross-reaction. The cross-reactivity of anti-DV NS1 antibodies with target proteins, and vice versa, indicated a molecular mimicry mechanism. Synthetic peptides of NS1 amino acid residues 311-330 (P311-330), a predicted epitope analyzed using homologous alignments between the C-terminus of DV2 NS1 and target proteins, were bound to anti-ATPase, anti-PDI, and anti-HSP60 antibodies, but much less to anti-vimentin antibodies. The cross-reactivity of dengue hemorrhagic fever (DHF) patient sera with HMEC-1 cells was blocked by P311-330 pre-absorption, which showed that anti-DV NS1-recognized molecules on the endothelial cell surface that may be involved in the pathogenesis of dengue hemorrhage, and that P311-330 is one of the shared epitopes between DV NS1 and its target proteins. Our previous study also showed that antibodies against DV NS1 cross-reacted with platelets. In this study, we demonstrate that protein disulfide isomerase (PDI) on platelet surface is recognized by anti-DV NS1 antibodies. Anti-DV NS1 inhibited PDI activity and platelet aggregation, and both inhibitory effects were prevented when anti-DV NS1 were pre-absorbed with PDI. Anti-PDI antibodies bound to P311-330. The platelet binding activities of anti-PDI and anti-DV NS1 antibodies were reduced by P311-330 pre-absorption. Similar to the findings using anti-DV NS1, antibodies against P311-330 bound to PDI and platelets, followed by inhibition of PDI activity and platelet aggregation. Furthermore, the cross-reactivity of DHF patient sera with platelets was reduced when patient sera were pre-absorbed with PDI or P311-330. DHF patient sera also inhibited platelet aggregation, and this inhibitory effect was blocked by PDI or P311-330 pre-absorption. Therefore, anti-DV NS1 antibodies cross-react with PDI on platelet surface causing inhibition of platelet aggregation, which may have implications in dengue disease pathogenesis. Moreover, the amino acid residues 311-330 of DV NS1 possess an important epitope, which is involved in the autoimmune response of DV pathogenesis.

    1. Chinese Abstract ..................I 2. English Abstract...................III 3. Acknowledgements................V 4. Contents..................VI 5. Index of Tables....................IX 6. Index of Figures...................X 7. Abbreviations..............XII 8. Introduction............1 9. Specific Aims.................10 10. Materials and Methods................11 I. Materials...........................11 I-1. Preparation of recombinant NS1................11 I-2. Mice...........................12 I-3. Generation of anti-NS1 antibodies...............12 I-4. Antibodies and reagents...................12 I-5. Patient sera........................13 I-6. Cell culture........................14 II. Methods...........................14 II-1. Extraction of endothelial cell membrane proteins.........14 II-2. Extraction of platelet membrane proteins............16 II-3. 2-DE separation......................16 II-4. Silver staining.......................17 II-5. Western blotting......................18 II-6. MS analysis and database searching..............18 II-7. Immunohistochemistry...................19 II-8. Pre-absorption and cell binding assay..............19 II-9. ELISA..........................20 II-10. Phage display peptide library................22 II-11. Peptide array.......................23 II-12. Analysis of thiol isomerase activity..............23 II-13. Analysis of ADP-stimulated platelet aggregation.........24 II-14. P-selectin expression in platelet...............25 II-15. Pre-absorption and platelet binding assay............25 II-16. Bioinformatic analysis...................26 II-17. Statistical analysis.....................26 11. Results.............................27 I. Molecular mimicry of anti-DV NS1 antibodies cross-reactive with endothelial cell.............................27 I-1. Endothelial cell membrane proteins recognized by anti-DV NS1...27 I-2. Candidate autoantigens are expressed on endothelial cell surfaces and co-localized with anti-NS1 binding sites.............29 I-3. Epitopes mapping of anti-DV NS1 antibodies...........29 I-4. P311-330 is a shared epitope between DV NS1 and target proteins..30 I-5. Endothelial cell-binding activity of DHF patient sera is inhibited by P311-330 pre-absorption...................31 II. Molecular mimicry of anti-DV NS1 antibodies cross-reactive with platelet............................31 II-1. PDI in platelet membrane extract is recognized by anti-DV NS1...31 II-2. Anti-DV NS1 inhibit thiol isomerase activity of PDI and platelet aggregation........................32 II-3. Determination of cross-reactive epitopes shared between PDI and DV NS1..........................33 II-4. Anti-P311-330 bind to PDI and inhibit platelet aggregation.....34 II-5. Platelet-binding activity of DHF patient sera is inhibited by P311-330 pre-absorption......................34 III. Clinical investigations using DHF patient sera............35 III-1. The levels of anti-target protein, anti-DV NS1 and anti-P311-330 antibodies in DHF patient sera................35 III-2. The relationship between anti-DV NS1, anti-target protein or anti-P311-330 antibodies and anti-endothelial cell or anti-platelet levels in DHF patient sera....................36 12. Discussion..............38 13. References.............58 14. Tables................79 15. Figures...............82 16. Appendix..............115

    References
    Alcon, S., Talarmin, A., Debruyne, M., Falconar, A., Deubel, V. & Flamand, M. (2002) Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol, 40, 376-381.
    Anderson, R., Wang, S., Osiowy, C. & Issekutz, A.C. (1997) Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol, 71, 4226-4232.
    Arakaki, N., Nagao, T., Niki, R., Toyofuku, A., Tanaka, H., Kuramoto, Y., Emoto, Y., Shibata, H., Magota, K. & Higuti, T. (2003) Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol Cancer Res, 1, 931-939.
    Avirutnan, P., Malasit, P., Seliger, B., Bhakdi, S. & Husmann, M. (1998) Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol, 161, 6338-6346.
    Avirutnan, P., Punyadee, N., Noisakran, S., Komoltri, C., Thiemmeca, S., Auethavornanan, K., Jairungsri, A., Kanlaya, R., Tangthawornchaikul, N., Puttikhunt, C., Pattanakitsakul, S.N., Yenchitsomanus, P.T., Mongkolsapaya, J., Kasinrerk, W., Sittisombut, N., Husmann, M., Blettner, M., Vasanawathana, S., Bhakdi, S. & Malasit, P. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis, 193, 1078-1088.
    Avirutnan, P., Zhang, L., Punyadee, N., Manuyakorn, A., Puttikhunt, C., Kasinrerk, W., Malasit, P., Atkinson, J.P. & Diamond, M.S. (2007) Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog, 3, e183.
    Bae, T.J., Kim, M.S., Kim, J.W., Kim, B.W., Choo, H.J., Lee, J.W., Kim, K.B., Lee, C.S., Kim, J.H., Chang, S.Y., Kang, C.Y., Lee, S.W. & Ko, Y.G. (2004) Lipid raft proteome reveals ATP synthase complex in the cell surface. Proteomics, 4, 3536-3548.
    Balmaseda, A., Hammond, S.N., Pérez, L., Tellez, Y., Saborío, S.I., Mercado, J.C., Cuadra, R., Rocha, J., Pérez, M.A., Silva, S., Rocha, C. & Harris, E. (2006) Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg, 74, 449-456.
    Barzilai, O., Ram, M. & Shoenfeld, Y. (2007) Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol, 19, 636-643.
    Bas de Laat, H., Derksen, R.H. & de Groot, P.G. (2004) beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol, 112, 161-168.
    Bason, C., Corrocher, R., Lunardi, C., Puccetti, P., Olivieri, O., Girelli, D., Navone, R., Beri, R., Millo, E., Margonato, A., Martinelli, N. & Puccetti, A. (2003) Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet, 362, 1971-1977.
    Basu, A. & Chaturvedi, U.C. (2008) Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol, 53, 287-299.
    Bell, S.E., Shah, C.M. & Gordge, M.P. (2007) Protein disulfide-isomerase mediates delivery of nitric oxide redox derivatives into platelets. Biochem J, 403, 283-288.
    Bhakdi, S. & Kazatchkine, M.D. (1990) Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J Trop Med Public Health, 21, 652-657.
    Bhamarapravati, N. (1989) Hemostatic defects in dengue hemorrhagic fever. Rev Infect Dis, 11 Suppl 4, S826-829.
    Bialek , K., Swistowski, A. & Frank, R. (2003) Epitope-targeted proteome analysis: towards a large-scale automated protein-protein-interaction mapping utilizing synthetic peptide arrays. Anal Bioanal Chem 376, 1006-1013.
    Blaney, J.E.Jr, Durbin, A.P., Murphy, B.R. & Whitehead, S.S. (2006) Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol, 19, 10-32.
    Brandt, W.E., McCown, J.M., Gentry, M.K. & Russell, P.K. (1982) Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun, 36, 1036-1041.
    Bruneel, A., Labas, V., Mailloux, A., Sharma, S., Vinh, J., Vaubourdolle, M. & Baudin, B. (2003) Proteomic study of human umbilical vein endothelial cells in culture. Proteomics, 3, 714-723.
    Burgess, J.K., Hotchkiss, K.A., Suter, C., Dudman, N.P., Szollosi, J., Chesterman, C.N., Chong, B.H. & Hogg, P.J. (2000) Physical proximity and functional association of glycoprotein 1balpha and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem, 275, 9758-9766.
    Cardier, J.E., Rivas, B., Romano, E., Rothman, A.L., Perez-Perez, C., Ochoa, M., Caceres, A.M., Cardier, M., Guevara, N. & Giovannetti, R. (2006) Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium, 13, 335-340.
    Chang, H.H., Shyu, H.F., Wang, Y.M., Sun, D.S., Shyu, R.H., Tang, S.S. & Huang, Y.S. (2002) Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J Infect Dis, 186, 743-751.
    Chen, H.C., Hofman, F.M., Kung, J.T., Lin, Y.D. & Wu-Hsieh, B.A. (2007) Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol, 81, 5518-5526.
    Chen, K., Detwiler, T.C. & Essex, D.W. (1995) Characterization of protein disulphide isomerase released from activated platelets. Br J Haematol, 90, 425-431.
    Chen, L.C., Lei, H.Y., Liu, C.C., Shiesh, S.C., Chen, S.H., Liu, H.S., Lin, Y.S., Wang, S.T., Shyu, H.W. & Yeh, T.M. (2006) Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg, 74, 142-147.
    Cheng, H.J., Lin, C.F., Lei, H.Y., Liu, H.S., Yeh, T.M., Luo, Y.H., & Lin, Y.S. (2009) Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Exp Biol Med, (In press)
    Clyde, K., Kyle, J.L. & Harris, E. (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol, 80, 11418-11431.
    Cosgriff, T.M. (1989) Viruses and hemostasis. Rev Infect Dis, 11 Suppl 4, S672-688.
    Diamond, M.S., Edgil, D., Roberts, T.G., Lu, B. & Harris, E. (2000) Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol, 74, 7814-7823.
    Dieudé, M., Senécal, J.L. & Raymond, Y. (2004) Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum, 50, 3221-3231.
    Dugue, C., Perraut, R., Youinou, P. & Renaudineau, Y. (2004) Effects of anti-endothelial cell antibodies in leprosy and malaria. Infect Immun, 72, 301-309.
    Essex, D.W., Chen, K. & Swiatkowska, M. (1995) Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood, 86, 2168-2173.
    Essex, D.W. & Li, M. (1999) Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol, 104, 448-454.
    Essex, D.W. & Li, M. (2006) Redox modification of platelet glycoproteins. Curr Drug Targets, 7, 1233-1241.
    Essex, D.W., Li, M., Miller, A. & Feinman, R.D. (2001) Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry, 40, 6070-6075.
    Faé, K.C., Diefenbach da Silva, D., Bilate, A.M., Tanaka, A.C., Pomerantzeff, P.M., Kiss, M.H., Silva, C.A., Cunha-Neto, E., Kalil, J. & Guilherme, L. (2008) PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J Autoimmun, 31, 136-141.
    Falconar, A.K. (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol, 142, 897-916.
    Falconar, A.K. (2007) Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design. Clin Vaccine Immunol, 14, 493-504.
    Fink, J., Gu, F. & Vasudevan, S.G. (2006) Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol, 16, 263-275.
    Flamand, M., Megret, F., Mathieu, M., Lepault, J., Rey, F.A. & Deubel, V. (1999) Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol, 73, 6104-6110.
    Funahara, Y., Ogawa, K., Fujita, N. & Okuno, Y. (1987) Three possible triggers to induce thrombocytopenia in dengue virus infection. Southeast Asian J Trop Med Public Health, 18, 351-355.
    Gagnon, S.J., Ennis, F.A. & Rothman, A.L. (1999) Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol, 73, 3623-3629.
    Ghosh, K., Gangodkar, S., Jain, P., Shetty, S., Ramjee, S., Poddar, P. & Basu, A. (2008) Imaging the interaction between dengue 2 virus and human blood platelets using atomic force and electron microscopy. J Electron Microsc, 57, 113-118.
    Goorha, R.M. & Gifford, G.E. (1971) Comparison of interferon induction by active and inactive Semliki Forest virus. J Gen Virol, 10, 117-124.
    Green, S. & Rothman, A. (2006) Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis, 19, 429-436.
    Green, S., Vaughn, D.W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B.L., Kurane, I., Rothman, A.L. & Ennis, F.A. (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis, 179, 755-762.
    Gubler, D.J. (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev, 11, 480-496.
    Guglielmone, H., Vitozzi, S., Elbarcha, O. & Fernandez, E. (2001) Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis, 60, 500-504.
    Guilarde, A.O., Turchi, M.D., Siqueira, J.B. Jr., Feres, V.C., Rocha, B., Levi, J.E., Souza, V.A., Boas, L.S., Pannuti, C.S. & Martelli, C.M. (2008) Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis, 197, 817-824.
    Halstead, S.B. (1988) Pathogenesis of dengue: challenges to molecular biology. Science, 239, 476-481.
    Halstead, S.B. (1989) Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis, 11 Suppl 4, S830-839.
    Halstead, S.B. (2002) Dengue. Curr Opin Infect Dis, 15, 471-476.
    Halstead, S.B. (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res, 60, 421-467.
    Halstead, S.B. (2007) Dengue. Lancet, 370, 1644-1652.
    Halstead, S.B. & O'Rourke, E.J. (1977a) Antibody-enhanced dengue virus infection in primate leukocytes. Nature, 265, 739-741.
    Halstead, S.B. & O'Rourke, E.J. (1977b) Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med, 146, 201-217.
    Hathirat, P., Isarangkura, P., Srichaikul, T., Suvatte, V. & Mitrakul, C. (1993) Abnormal hemostasis in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health, 24 Suppl 1, 80-85.
    Henchal, E.A., Henchal, L.S., & Schlesinger, J.J. (1988) Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue-2 virus. J Gen Virol, 209, 2101-2107.
    Henchal, E.A. & Putnak, J.R. (1990) The dengue viruses. Clin Microbiol Rev, 3, 376-396.
    Higuchi, T., Watanabe, Y. & Waga, I. (2004) Protein disulfide isomerase suppresses the transcriptional activity of NF-kappa B. Biochem Biophys Res Commun, 318, 46-52.
    Ho, L.J., Wang, J.J., Shaio, M.F., Kao, C.L., Chang, D.M., Han, S.W. & Lai, J.H. (2001) Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol, 166, 1499-1506.
    Homan, S.M., Martinez, R., Benware, A. & LaFlamme, S.E. (2002) Regulation of the association of alpha 6 beta 4 with vimentin intermediate filaments in endothelial cells. Exp Cell Res, 281, 107-114.
    Huang, J.L., Huang, J.H., Shyu, R.H., Teng, C.W., Lin, Y.L., Kuo, M.D., Yao, C.W. & Shaio, M.F. (2001) High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen. J Med Virol, 65, 553-560.
    Huang, K.J., Li, S.Y., Chen, S.C., Liu, H.S., Lin, Y.S., Yeh, T.M., Liu, C.C. & Lei, H.Y. (2000a) Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol, 81, 2177-2182.
    Huang, K.J., Yang, Y.C., Lin, Y.S., Huang, J.H., Liu, H.S., Yeh, T.M., Chen, S.H., Liu, C.C. & Lei, H.Y. (2006) The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol, 176, 2825-2832.
    Huang, Y.H., Chang, B.I., Lei, Y.H., Liu, H.S., Liu, C.C., Wu, H.L. & Yeh, T.M. (1997) Antibodies against dengue virus E protein peptide bind to human plasminogen and inhibit plasmin activity. Clin Exp Immunol, 110, 35-40.
    Huang, Y.H., Lei, H.Y., Liu, H.S., Lin, Y.S., Liu, C.C. & Yeh, T.M. (2000b) Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg, 63, 71-75.
    Huerta-Zepeda, A., Cabello-Gutierrez, C., Cime-Castillo, J., Monroy-Martinez, V., Manjarrez-Zavala, M.E., Gutierrez-Rodriguez, M., Izaguirre, R. & Ruiz-Ordaz, B.H. (2008) Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost, 99, 936-943.
    Jacobs, M.G., Robinson, P.J., Bletchly, C., Mackenzie, J.M. & Young P.R. (2000) Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J, 14, 1603-1610.
    Jacobs, S.C., Stephenson, J.R. & Wilkinson, G.W. (1994) Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J Gen Virol, 75, 2399-2402.
    Jantos, C.A., Krombach, C., Wuppermann, F.N., Gardemann, A., Bepler, S., Asslan, H., Hegemann, J.H. & Haberbosch, W. (2000) Antibody response to the 60-kDa heat-shock protein of Chlamydia pneumoniae in patients with coronary artery disease. J Infect Dis, 181, 1700-1705.
    Jason, M.M., Malcolm, K.J., & Paul, R.Y. (1996) Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology, 220, 232-240.
    Jessie, K., Fong, M.Y., Devi, S., Lam, S.K. & Wong, K.T. (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis, 189, 1411-1418.
    Jordan, P.A., Stevens, J.M., Hubbard, G.P., Barrett, N.E., Sage, T., Authi, K.S. & Gibbins, J.M. (2005) A role for the thiol isomerase protein ERP5 in platelet function. Blood, 105, 1500-1507.
    Kalayanarooj, S., Vaughn, D.W., Nimmannitya, S., Green, S., Suntayakorn, S., Kunentrasai, N., Viramitrachai, W., Ratanachu-eke, S., Kiatpolpoj, S., Innis, B.L., Rothman, A.L., Nisalak, A. & Ennis, F.A. (1997) Early clinical and laboratory indicators of acute dengue illness. J Infect Dis, 176, 313-321.
    Kaufman, B.M., Summers, P.L., Dubois, D.R., Cohen, W.H., Gentry, M.K., Timchak, R.L., Burke, D.S. & Eckels, K.H. (1989) Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg, 41, 576-580.
    Kelton, J.G. (1987) Platelet and red cell clearance is determined by the interaction of the IgG and complement on the cells and the activity of the reticuloendothelial system. Transfus Med Rev, 1, 75-84.
    Kelton, J.G. (2002) Heparin-induced thrombocytopenia: an overview. Blood Rev, 16, 77-80.
    Kim, B., Kaistha, S.D. & Rouse, B.T. (2006) Viruses and autoimmunity. Autoimmunity, 39, 71-77.
    Kim, B.W., Choo, H.J., Lee, J.W., Kim, J.H. & Ko, Y.G. (2004) Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp Mol Med, 36, 476-485.
    King, C.A., Marshall, J.S., Alshurafa, H. & Anderson, R. (2000) Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol, 74, 7146-7150.
    Krishnamurti, C., Peat, R.A., Cutting, M.A. & Rothwell, S.W. (2002) Platelet adhesion to dengue-2 virus-infected endothelial cells. Am J Trop Med Hyg, 66, 435-441.
    Kumarasamy, V., Chua, S.K., Hassan, Z., Wahab, A.H., Chem, Y.K., Mohamad, M. & Chua, K.B. (2007) Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection. Singapore Med J, 48, 669-673.
    Lahav, J., Gofer-Dadosh, N., Luboshitz, J., Hess, O. & Shaklai, M. (2000) Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett, 475, 89-92.
    Lahav, J., Jurk, K., Hess, O., Barnes, M.J., Farndale, R.W., Luboshitz, J. & Kehrel, B.E. (2002) Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood, 100, 2472-2478.
    Lahav, J., Wijnen, E.M., Hess, O., Hamaia, S.W., Griffiths, D., Makris, M., Knight, C.G., Essex, D.W. & Farndale, R.W. (2003) Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood, 102, 2085-2092.
    Lee, Y.R., Liu, M.T., Lei, H.Y., Liu, C.C., Wu, J.M., Tung, Y.C., Lin, Y.S., Yeh, T.M., Chen, S.H. & Liu, H.S. (2006) MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol, 87, 3623-3630.
    Legastelois, I., Levrey, H., Greenland, T., Mornex, J.F. & Cordier, G. (1998) Visna-maedi virus induces interleukin-8 in sheep alveolar macrophages through a tyrosine-kinase signaling pathway. Am J Respir Cell Mol Biol, 18, 532-537.
    Lei, H.Y., Yeh, T.M., Liu, H.S., Lin, Y.S., Chen, S.H. & Liu, C.C. (2001) Immunopathogenesis of dengue virus infection. J Biomed Sci, 8, 377-388.
    Lei, H.Y., Huang, K.J., Lin, Y.S., Yeh, T.M., Liu, H.S. & Liu, C.C. (2008) Immunopathogenesis of dengue hemorrhagic fever. Am J Infect Dis, 4, 1-9.
    Leitmeyer, K.C., Vaughn, D.W., Watts, D.M., Salas, R., Villalobos, I., de, C., Ramos, C. & Rico-Hesse, R. (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol, 73, 4738-4747.
    Li, Z., Nardi, M.A. & Karpatkin, S. (2005) Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood, 106, 572-576.
    Libraty, D.H., Young, P.R., Pickering, D., Endy, T.P., Kalayanarooj, S., Green, S., Vaughn, D.W., Nisalak, A., Ennis, F.A. & Rothman, A.L. (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis, 186, 1165-1168.
    Limonta, D., Capo, V., Torres, G., Perez, A.B. & Guzman, M.G. (2007) Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol, 40, 50-54.
    Limkittikul, K., Yingsakmongkon, S., Jittmittraphap, A., Chuananon, S., Kongphrai, Y., Kowasupathr, S., Rojanawatsirivit, C., Mammen, M.P. Jr & Jampangern, W. (2005) Clinical differences among PCR-proven dengue serotype infections. Southeast Asian J Trop Med Public Health, 36, 1432-1438.
    Lin, C.F., Chiu, S.C., Hsiao, Y.L., Wan, S.W., Lei, H.Y., Shiau, A.L., Liu, H.S., Yeh, T.M., Chen, S.H., Liu, C.C. & Lin, Y.S. (2005a) Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol, 174, 395-403.
    Lin, C.F., Lei, H.Y., Liu, C.C., Liu, H.S., Yeh, T.M., Wang, S.T., Yang, T.I., Sheu, F.C., Kuo, C.F. & Lin, Y.S. (2001) Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol, 63, 143-149.
    Lin, C.F., Lei, H.Y., Shiau, A.L., Liu, C.C., Liu, H.S., Yeh, T.M., Chen, S.H. & Lin, Y.S. (2003) Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol, 69, 82-90.
    Lin, C.F., Lei, H.Y., Shiau, A.L., Liu, H.S., Yeh, T.M., Chen, S.H., Liu, C.C., Chiu, S.C. & Lin, Y.S. (2002) Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol, 169, 657-664.
    Lin, C.F., Wan, S.W., Cheng, H.J., Lei, H.Y. & Lin, Y.S. (2006) Autoimmune pathogenesis in dengue virus infection. Viral Immunol, 19, 127-132.
    Lin, C. F., Wan, S.W., Chen, M.C., Lin, S.C., Cheng, C.C., Chiu, S.C., Hsiao, Y.L., Lei, H.Y., Liu, H.S., Yeh, T.M. & Lin, Y.S. (2008a) Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab Invest, 88, 1079-1089.
    Lin, C.F., Lei, H.Y., Liu, C.C., Liu, H.S., Yeh, T.M., Anderson, R. & Lin, Y. S. (2008b) Patient and mouse antibodies against dengue virus nonstructural protein 1 cross-react with platelets and cause their dysfunction or depletion. Am J Infect Dis, 4, 69-75.
    Lin, Y.S., Lin, C.F., Fang, Y.T., Kuo, Y.M., Liao, P.C., Yeh, T.M., Hwa, K.Y., Shieh, C.C., Yen, J.H., Wang, H.J., Su, I.J. & Lei, H.Y. (2005b) Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol, 141, 500-508.
    Lin, Y.S., Lin, C.F., Lei, H.Y., Liu, H.S., Yeh, T.M., Chen, S.H. & Liu, C.C. (2004) Antibody-mediated endothelial cell damage via nitric oxide. Curr Pharm Des, 10, 213-221.
    Littaua, R., Kurane, I. & Ennis, F.A. (1990) Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol, 144, 3183-3186.
    Lu, Y., Ye, P., Chen, S.L., Tan, E.M. & Chan, E.K. (2005) Identification of kinectin as a novel Behçet's disease autoantigen. Arthritis Res Ther 7, R1133-1139.
    Lunardi, C., Bason, C., Navone, R., Millo, E., Damonte, G., Corrocher, R. & Puccetti, A. (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med, 6, 1183-1186.
    Mady, B.J., Erbe, D.V., Kurane, I., Fanger, M.W. & Ennis, F.A. (1991) Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol, 147, 3139-3144.
    Manickam, N., Sun, X., Li, M., Gazitt, Y. & Essex, D.W. (2008) Protein disulphide isomerase in platelet function. Br J Haematol, 140, 223-229.
    Mathew, A., Kurane, I., Green, S., Vaughn, D.W., Kalayanarooj, S., Suntayakorn, S., Ennis, F.A. & Rothman, A.L. (1999) Impaired T cell proliferation in acute dengue infection. J Immunol, 162, 5609-5615.
    Mathew, A. & Rothman, A.L. (2008) Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev, 225, 300-313.
    Maya, R., Gershwin, M.E. & Shoenfeld, Y. (2008) Hepatitis B Virus (HBV) and Autoimmune Disease. Clin Rev Allergy Immunol, 34, 85-102.
    McKenzie, S.E. & Reilly, M.P. (2004) Heparin-induced thrombocytopenia and other immune thrombocytopenias: lessons from mouse models. Semin Thromb Hemost, 30, 559-568.
    Men, R.H., Bray, M. & Lai, C.J. (1991) Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. J Virol, 65, 1400-1407.
    Molina, V. & Shoenfeld, Y. (2005) Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity, 38, 235-245.
    Mukhopadhyay, S., Kuhn, R.J. & Rossmann, M.G.. (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol, 3, 13-22.
    Monath, T.P. (1994) Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA, 91, 2395-2400.
    Morens, D.M. (1994) Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis, 19, 500-512.
    Morens, D.M., Venkateshan, C.N. & Halstead, S.B. (1987) Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses. J Gen Virol, 68 ( Pt 1), 91-98.
    Moser, T.L., Kenan, D.J., Ashley, T.A., Roy, J.A., Goodman, M.D., Misra, U.K., Cheek, D.J. & Pizzo, S.V. (2001) Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci U S A, 98, 6656-6661.
    Moser, T.L., Stack, M.S., Asplin, I., Enghild, J.J., Hojrup, P., Everitt, L., Hubchak, S., Schnaper, H.W. & Pizzo, S.V. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci U S A, 96, 2811-2816.
    Musante, L., Candiano, G., Bruschi, M., Santucci, L., Carnemolla, B., Orecchia, P., Giampuzzi, M., Zennaro, C., Sanna-Cherchi, S., Carraro, M., Oleggini, R., Camussi, G., Perfumo, F. & Ghiggeri, G.M. (2005) Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. Clin Exp Immunol, 141, 491-499.
    Nardi, M., Feinmark, S.J., Hu, L., Li, Z. & Karpatkin, S. (2004) Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest, 113, 973-980.
    Ng, M.L. & Corner, L.C. (1989) Detection of some dengue-2 virus antigens in infected cells using immuno-microscopy. Arch Virol, 104, 197-208.
    Nguyen, T.H., Lei, H.Y., Nguyen, T.L., Lin, Y.S., Huang, K.J., Le, B.L., Lin, C.F., Yeh, T.M., Do, Q.H., Vu, T.Q., Chen, L.C., Huang, J.H., Lam, T.M., Liu, C.C. & Halstead, S.B. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis, 189, 221-232.
    Noisakran, S. & Perng, G.C. (2008) Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp Biol Med (Maywood), 233, 401-408.
    Oishi, K., Inoue, S., Cinco, M.T., Dimaano, E.M., Alera, M.T., Alfon, J.A., Abanes, F., Cruz, D.J., Matias, R.R., Matsuura, H., Hasebe, F., Tanimura, S., Kumatori, A., Morita, K., Natividad, F.F. & Nagatake, T. (2003) Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol, 71, 259-264.
    Parera, R. & Kuhn, R.J. (2008) Structural proteomics of dengue virus. Curr Opin Microbiol, 11, 369-377.
    Pfister, G., Stroh, C.M., Perschinka, H., Kind, M., Knoflach, M., Hinterdorfer, P. & Wick, G. (2005) Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci, 118, 1587-1594.
    Porta, C., Caporali, R. & Montecucco, C. (1999) Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica, 84, 260-269.
    Qu, X., Chen, W., Maguire, T. & Austin, F. (1993) Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system. J Gen Virol, 74, 89-97.
    Rand, M.L. & Wright, J.F. (1998) Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci, 19, 253-259.
    Rothman, A.L. & Ennis, F.A. (1999) Immunopathogenesis of Dengue hemorrhagic fever. Virology, 257, 1-6.
    Rothman, A.L., Kanesa-thasan, N., West, K., Janus, J., Saluzzo, J. & Ennis, F.A. (2001) Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine. Vaccine, 19, 4694–4699.
    Rouse, B.T. & Deshpande, S. (2002) Viruses and autoimmunity: an affair but not a marriage contract. Rev Med Virol, 12, 107-113.
    Saadi, S. & Platt, J.L. (1995) Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med, 181, 21-31.
    Saito, M., Oishi, K., Inoue, S., Dimaano, E.M., Alera, M.T., Robles, A.M., Estrella, B.D., Jr., Kumatori, A., Moji, K., Alonzo, M.T., Buerano, C.C., Matias, R.R., Morita, K., Natividad, F.F. & Nagatake, T. (2004) Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol, 138, 299-303.
    Salentin, R., Gemsa, D., Sprenger, H. & Kaufmann, A. (2003) Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection. J Leukoc Biol, 74, 252-259.
    Schett, G., Xu, Q., Amberger, A., Van der Zee, R., Recheis, H., Willeit, J. & Wick, G. (1995) Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest, 96, 2569-2577.
    Schlesinger, J.J., Brandris, M.W. & Walsh, E.E. (1987) Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol, 68, 853-857.
    Schlesinger, J.J., Foltzer, M. & Chapman, S. (1993) The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology, 192, 132-141
    Shasby, D.M., Ries, D.R., Shasby, S.S. & Winter, M.C. (2002) Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. Am J Physiol Lung Cell Mol Physiol, 282, L1330-1338.
    Shattil, S.J., Kashiwagi, H. & Pampori, N. (1998) Integrin signaling: the platelet paradigm. Blood, 91, 2645-2657.
    Shu, P.Y., Chen, L.K., Chang, S.F., Yueh, Y.Y., Chow, L., Chien, L.J., Chin, C., Lin, T.H. & Huang, J.H. (2000) Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J Med Virol, 62, 224-232.
    Shu, P.Y., Chen, L.K., Chang, S.F., Yueh, Y.Y., Chow, L., Chien, L.J., Chin, C., Lin, T.H. & Huang, J.H. (2003) Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol, 10, 622-630.
    Sosothikul, D., Seksarn, P., Pongsewalak, S., Thisyakorn, U. & Lusher, J. (2007) Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection. Thromb Haemost, 97, 627-634.
    Stulík, J., Hernychová, L., Porkertová, S., Pozler, O., Tucková, L., Sánchez, D. & Bures, J. (2003) Identification of new celiac disease autoantigens using proteomic analysis. Proteomics, 3, 951-956.
    Sun, D.S., King, C.C., Huang, H.S., Shih, Y.L., Lee, C.C., Tsai, W.J., Yu, C.C. & Chang, H.H. (2007) Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost, 5, 2291-2299.
    Tanaka, S., Uehara, T. & Nomura, Y. (2000) Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Biol Chem, 275, 10388-10393.
    Thomas, D., Karachaliou, F., Kallergi, K., Vlachopapadopoulou, E., Antonaki, G., Chatzimarkou, F., Fotinou, A., Kaldrymides, P. & Michalacos, S. (2008) Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine, 33, 171-175.
    Turano, C., Coppari, S., Altieri, F. & Ferraro, A. (2002) Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol, 193, 154-163.
    Tzang, B.S., Tsay, G.J., Lee, Y.J., Li, C., Sun, Y.S. & Hsu, T.C. (2007) The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production. Clin Chim Acta, 378, 59-65.
    Valero, N. & Levy, A. (2008) Future prospects in developing of dengue vaccines. Invest Clin, 49, 135-138.
    Vaughn, D.W., Green, S., Kalayanarooj, S., Innis, B.L., Nimmannitya, S., Suntayakorn, S., Endy, T.P., Raengsakulrach, B., Rothman, A.L., Ennis, F.A. & Nisalak, A. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis, 181, 2-9.
    Veitonmaki, N., Cao, R., Wu, L.H., Moser, T.L., Li, B., Pizzo, S.V., Zhivotovsky, B. & Cao, Y. (2004) Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Cancer Res, 64, 3679-3686.
    Vuori, K., Pihlajaniemi, T., Myllyla, R. & Kivirikko, K.I. (1992) Site-directed mutagenesis of human protein disulphide isomerase: effect on the assembly, activity and endoplasmic reticulum retention of human prolyl 4-hydroxylase in Spodoptera frugiperda insect cells. Embo J, 11, 4213-4217.
    Wallis, T.P., Huang, C.Y., Nimkar, S.B., Young, P.R. & Gorman, J.J. (2004) Determination of the disulfide bond arrangement of dengue virus NS1 protein. J Biol Chem, 279, 20729-20741.
    Wang, S., He, R., Patarapotikul, J., Innis, B.L. & Anderson, R. (1995) Antibody-enhanced binding of dengue-2 virus to human platelets. Virology, 213, 254-257.
    Whitehead, S.S., Blaney, J.E., Durbin, A.P. & Murphy, B.R. (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol, 5, 518-528.
    Wick, G., Perschinka, H. & Millonig, G. (2001) Atherosclerosis as an autoimmune disease: an update. Trends Immunol, 22, 665-669.
    Yazici, Z.A., Behrendt, M., Cooper, D., Goodfield, M., Partridge, L. & Lindsey, N.J. (2000) The identification of endothelial cell autoantigens. J Autoimmun, 15, 41-49.
    Youinou, P. (2005) New target antigens for anti-endothelial cell antibodies. Immunobiology, 210, 789-797.
    Young, P.R., Hilditch, P.A., Bletchly, C. & Halloran, W. (2000) An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol, 38, 1053-1057.
    Zai, A., Rudd, M.A., Scribner, A.W. & Loscalzo, J. (1999) Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest, 103, 393-399.
    Zhang, B., Zhang, Y., Wang, J., Zhang, Y., Chen, J., Pan, Y., Ren, L., Hu, Z., Zhao, J., Liao, M. & Wang, S. (2007) Screening and identification of a targeting Peptide to hepatocarcinoma from a phage display peptide library. Mol Med, 13, 246-254.

    下載圖示 校內:2011-12-17公開
    校外:2011-12-17公開
    QR CODE